Teva Expected to Fire Up to 1,700 Workers in Israel, U.S.
News of the layoffs comes hard on the heels of the company's credit rating having been cut to junk status by Fitch Rating. Source: BioSpace
Teva Shakes Up C-Suite in Restructuring
Since taking over at Teva earlier this fall, Kare Schultz has been swiftly moving to shore up the finances and pay down the massive debts of the beleaguered pharmaceutical company.…
Biogen Forges $278M MS Tie-Up With Alkermes
Biogen will receive an exclusive, worldwide license to commercialize ALKS 8700 and will pay Alkermes a mid-teens royalty on worldwide net sales of ALKS 8700. Source: BioSpace
Bay Area's Medeor Therapeutics Bags $57M
The financing will be used to push its Phase III clinical program of MDR-101 in living donor HLA-matched kidney transplant patients. Source: BioSpace
PhRMA, AAM Spar on Hatch-Waxman Provisions
The Hatch-Waxman Act did not strike a good balance between generic access and brand-name innovation, according to public comments to the FDA from both PhRMA and the Association for Accessible…
UK Watchdog Claims Concordia Overcharged for Generic Thyroid Medication
The UK’s competition watchdog agency claimed the drugmaker Concordia overcharged the NHS by millions for its hypothyroid medication liothyronine, also known as Cytomel, following price increases of almost 6,000 percent…
Biologics Manufacturers Need More Adaptable, Modular Strategies: Tufts Study
Makers of biopharmaceuticals will need to become more modular and agile to adjust for trends in personalized medicine and oncology, according to the Tufts Center for the Study of Drug…
Judge Rejects Aegerion Plea Deal for Deceptive Cholesterol Drug Marketing
A federal judge blocked Aegerion’s proposed $36 million deal to settle claims of illegal marketing tactics for its cholesterol drug Juxtapid, ordering the case to trial. Source: Drug Industry Daily
EMA’s New EudraVigilance System Goes Live
The European Medicines Agency launched the new version of its EudraVigilance adverse event database Nov. 22, providing more tools for analysis. Source: Drug Industry Daily
Heptares Founder Shares Her Best Life Sciences Career Advice
Fiona Marshall founded Heptares Therapeutics, which is now one of the leading biotech companies in the UK. Source: BioSpace
- Go to the previous page
- 1
- …
- 247
- 248
- 249
- 250
- 251
- 252
- 253
- …
- 610
- Go to the next page